☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Biogen Signs an Exclusive Commercialization Agreement with Samsung Bioepis to Expand its Biosimilars Portfolio
November 7, 2019
Coherus Signs an Exclusive License Agreement with Bioeq for Biosimilar of Lucentis (ranibizumab) in the US
November 7, 2019
Promega Signs a Worldwide Agreement with Merck to Develop MSI Technology as CDx for Keytruda
November 7, 2019
Novo Nordisk Signs an Exclusive Worldwide License Agreement with UBE Industries for its UD-014
November 7, 2019
STADA Signs an Exclusive Commercialization Agreement with Alvotech for Seven Biosimilars in Europe
November 7, 2019
AstraZeneca to Invest $1B for the Transformation of Healthcare in China
November 7, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions